Philips nets FDA nod for CT lung cancer screening

AuntMinnie.com staff writers
Apr 25, 2016

Philips Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of its CT product suite in low-dose lung cancer screening.

The FDA clearance encompasses the vendor's suite of 27 CT and PET/CT scanners, as well as integrated software and services. Philips said healthcare organizations of all sizes can now utilize existing systems to implement low-dose CT lung cancer screening programs.

Philips highlighted a number of benefits from its lung cancer screening technology, including dose-management software, "control center" software that provides referring physicians with digital access to patient-tracking data, and image data sharing and analytics capabilities via its IntelliSpace Portal software.

The vendor also said that version 8.0 of IntelliSpace Portal now includes its CT Lung Nodule Assessment application.

Latest in CT
3 D Lungs Covid Virus Cells
CT reveals influence of diabetes on COVID-19 severity
April 25, 2024
Lung Illustration Blue
Clinical practice LCS program finds more disease than NLST
April 24, 2024
You think ahead. We innovate ahead.
Sponsored
You think ahead. We innovate ahead.
April 25, 2024
Doctor Female Young Desk 400
Radiologist consultation improves patients' LCS attitudes
April 18, 2024
Related Stories
2016 03 04 15 55 35 985 Philips Ingenia 1 5 T S 200
IS
Philips highlights data analytics at ECR 2016
2014 07 18 14 26 51 127 Brain General 200
CT
Choosing unwisely: Lung cancer patients get brain scans
2016 04 19 14 20 06 112 2016 04 15 Culprit Fuller 400 20160419212020
CT
CCTA falls short in detection of culprit plaque
You think ahead. We innovate ahead.
Sponsor Content
You think ahead. We innovate ahead.
More in CT
CT reveals influence of diabetes on COVID-19 severity
By Kate Madden Yee
CT imaging reveals the influence of blood glucose levels on the severity of COVID-19, researchers have reported.
April 25, 2024
3 D Lungs Covid Virus Cells
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
A clinical practice lung cancer screening (LCS) program at Duke University Medical Center found more disease than did the National Lung Screening Trial (NLST).
April 24, 2024
Lung Illustration Blue
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
CT-FFR reduces invasive procedures for coronary artery blockages
By Kate Madden Yee
CT fractional flow reserve (CT-FFR) imaging identifies patients with coronary artery blockage or narrowing who could benefit from revascularization -- and helps reduce the unnecessary use of invasive procedures, researchers have found.
April 11, 2024
Heart Pulmonary Trunk
Experts say consider BMI when imaging patients with chest pain
By Will Morton
A patient’s body mass index (BMI) has a significant effect on how much radiation exposure they receive from chest imaging in cases of suspected cardiac ischemia.
April 11, 2024
Heart Attack
AI model predicts invasiveness of lung cancer on CT scans
By Will Morton
Radiologists in Beijing, China, have developed a joint deep-learning and radiomics AI model that can flag how invasive tumors may be in patients with lung cancer.
April 9, 2024
Lung Ai
Is CTA overused in the emergency department?
By Amerigo Allegretto
CT angiography (CTA) may be overused in the emergency department, new research suggests.
April 1, 2024
Patient Elderly Confused Headache 400
Deep learning helps distinguish benign vertebral fractures on CT
By Kate Madden Yee
A deep-learning algorithm used with CT imaging can differentiate between benign and malignant vertebral fractures, researchers have found.
March 27, 2024
Overview of the automated deep learning-based pipeline. Multidetector CT images show the (A) original data, (B, C) vertebral segmentation, and (D-F) vertebral labeling during preprocessing. Images and caption courtesy of the RSNA.
The rise of theranostics: Part 1 -- Gaining momentum
By Liz Carey
FDA-approved radiopharmaceuticals have energized the field of theranostics. In part 1 of a series, experienced theranostics leaders offer implications of the latest clinical trials, how a theranostics clinic works, and advice for introducing theranostics.
March 26, 2024
Team members from the theranostics clinic under University of Texas Health Science Center at San Antonio's Department of Radiology show one aspect of a Pluvicto infusion treatment. The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. (Photo courtesy of UT Health San Antonio Department of Radiology)
Page 1 of 654
Next Page